Achieve Excellence Together

Our Leadership

Damien Burke

Chief Executive Officer

Damien joined EirGen in 2006 as one of the originating members of the start-up team. Damien has worked in diverse roles across the pharmaceutical sector including research and development, manufacturing and packaging operations, artwork management and packaging technology.

He has worked in previously in TEVA pharmaceuticals. At EirGen, he was Head of Commercial Operations for several years before being appointed to his current role as Chief Executive Officer in October 2019.

Damien holds an MSc in Supply Chain & Operations Management from the University of Liverpool, BSc in Pharmaceutical Science from WIT and a Diploma in Packaging Technology from the Institute of Packaging

Kay O’Shea

Chief Technical Officer

Kay joined EirGen in 2010 having been an external consultant for the previous five years. She has worked in diverse roles across the pharmaceutical sector including regulatory affairs, research and development, clinical research and project management.

She previously worked with Clonmel Healthcare and Teva as well as running her own consultancy.

At EirGen, she was Head of Scientific Affairs for several years before being appointed to her current role as Chief Technical Officer in November 2019. She leads the core technical functions of R&D, Scientific Affairs and Quality. Kay also has overall responsibility for Regulatory and Clinical Affairs and was responsible for setting up a Project Management Office (PMO) for the company to enable delivery of projects on multiple platforms.

She holds a BSc degree in Industrial Chemistry from University of Limerick.

Joanne Jacques

Head of Sterile Operations

Joanne is a senior manufacturing executive with 20+ years in the pharma/biotechnology industry with experience in API, solid oral dose and sterile final products.

Jo’s key skills are building high performance teams, strategic planning, understanding and application of value streams and a high knowledge of GMP compliance against multiple regulatory agencies.

Her previous roles include site director at Dechra Pharmaceuticals in The Netherlands, where she established a cultural change programme, provided oversight on major investment programme and developed senior leaders, She has also previously worked in a Head of Manufacturing role with Ipsen and Head of Fill Finish with Alvotech. Earlier in her career, she was a Project Manager and later Director – Programme Management with MediImmune.

She has a proven track record of building operational teams delivering to a key strategic direction.

She holds a BSc in Biomedical Sciences from the University of Sunderland

Gillian Prendergast

Head of Scientific Affairs

Gillian joined EirGen in 2018 as Regulatory Affairs Manager and became Head of Scientific Affairs in May 2019.

She has more than 20 years’ pharma industry experience across Regulatory Affairs, Clinical Affairs and Analytical Chemistry – both large and small molecule. Gillian previously worked with Teva Pharmaceuticals; Eurofins Scientific; Pinewood Healthcare and Acorn Regulatory Consultancy Services.

She holds a BSc in Chemistry, Biology and Mathematics from Maynooth University.

Dan Delaney

Head of Commercial Operations

Dan joined EirGen in 2015 as Supply Chain Manager and became Head of Commercial Operations in December 2019.

He has more than 30 years‘ industry operations experience, starting in engineering, with roles as software engineer and process control engineer before moving onto leadership roles and subsequently into a Supply Chain lead role with Honeywell Process Solutions before joining EirGen. Dan has also worked with Measurex Ireland and Measurex Asia as well as Kentz Engineering and Honeywell.

He is an engineering graduate of Waterford Institute of Technology.

Bill Murphy

Bill joined EirGen in February 2020.

He has more than 30 years’ leadership experience in the biopharmaceutical sector and was previously Head of Finance at Sanofi Waterford while he has also worked in multi-country and multi-site roles at the French multinational. Bill has also held finance leadership roles with Boston Scientific, Abbott, Lowe Alpine Systems and American Home Products.

A chartered management accountant, he has experience in Business Information Systems; Operational Excellence; Supply Chain; Procurement and Human Resources.

At EirGen, he leads the finance and I.T. functions and is contributing to strategic development and growth.

Mike Walsh

Head of Quality

Mike joined EirGen in April 2020 as Head of Quality. He has over 25 years’ pharma and biotech experience and has held a variety of leadership positions in Quality, Operations, Engineering and External Contract Manufacturing.

Mike began his career in 1994 at GSK Dungarvan, working in Packaging Operations and, subsequently, in Q.A./Validation.

In 2002, Mike moved to Genzyme (now Sanofi Waterford) gaining a broad range of experience during the site’s multi-year start-up, holding positions with increasing responsibility in Quality, Fill Finish and Oral Dose Manufacturing. In 2011, Mike relocated to Massachusetts where he held director level roles in Q.A. and Q.C. at Genzyme Biologics, supporting the successful start-up of a Biologics Drug Substance facility, while helping transform the company’s Quality Systems. In 2016, Mike returned to Ireland, taking on the role as Q.A. Lead Manager at the Sanofi Waterford site, reporting to the Head of Quality.

Mike has also held positions with Amgen, including as a Snr Manager, Process Engineering at their packaging and distribution centre located in Breda, Netherlands and as Snr Q.A. Manager in EU Contract Manufacturing.

He is a graduate of Waterford Institute of Technology and Strathclyde University, Scotland